Infectious Disease Clinical Trial Award
The Infectious Disease Clinical Trial Award provides a significant funding opportunity for researchers focused on infectious diseases. This award supports large-scale, high-impact clinical trials aimed at optimizing existing pharmaceutical interventions in low- and middle-income countries. The goal is to generate evidence that informs policy and clinical practice, ultimately improving health outcomes in vulnerable populations.
With funding amounts ranging from £1 million to £8 million, this program encourages transdisciplinary research teams to conduct randomized controlled trials (RCTs) that address critical health challenges. Successful projects are expected to deliver measurable impacts, particularly in regions most affected by infectious diseases.
Eligibility
This funding opportunity is open to research teams based in:
- Africa
- South Asia
- South-East Asia (excluding mainland China)
Key requirements include:
- A lead applicant and at least one co-applicant based in eligible regions.
- At least 50% of the team must be located in these regions.
- Teams can consist of up to eight applicants (plus collaborators).
- Applicants must be affiliated with eligible institutions such as universities, research institutes, healthcare organizations, or non-profits.
Deadline: Ongoing
Benefits
Funding covers staff salaries, equipment and materials, clinical trial and fieldwork costs, and travel expenses.
